InvestSMART

InteliCare Holdings Limited (ASX: ICR) - Announcements

- Current share price for ICR : $0.025

ASX company news and announcements for InteliCare Holdings Limited (ICR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All InteliCare Holdings Limited (ICR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than InteliCare Holdings Limited (ICR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for InteliCare Holdings Limited (ICR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18 Short Form Notice of GM 15 Jun 2022 4:38PM $0.043 $0.025 fallen by 41.86%
$18 Notice of General Meeting/Proxy Form 15 Jun 2022 4:37PM $0.043 $0.025 fallen by 41.86%
$18 Cancel - Application for quotation of securities - ICR 27 May 2022 11:28AM $0.069 $0.025 fallen by 63.77%
$18 Application for quotation of securities - ICR 26 May 2022 7:27PM $0.069 $0.025 fallen by 63.77%
$18 Application for quotation of securities - ICR 26 May 2022 5:47PM $0.069 $0.025 fallen by 63.77%
$18 Unlisted Securities Released from Escrow 26 May 2022 2:34PM $0.069 $0.025 fallen by 63.77%
$18 Notification of Release of Shares from Escrow 24 May 2022 1:29PM $0.070 $0.025 fallen by 64.29%
$18 Quarterly Activities/Appendix 4C Cash Flow Report 29 Apr 2022 11:17AM $0.088 $0.025 fallen by 71.59%
$18 Quarterly Activities Report 29 Apr 2022 11:15AM $0.088 $0.025 fallen by 71.59%
$18 Initial Director's Interest Notice 27 Apr 2022 3:58PM $0.095 $0.025 fallen by 73.68%
$18 Initial Director's Interest Notice 27 Apr 2022 3:57PM $0.095 $0.025 fallen by 73.68%
$18 Final Director's Interest Notice 27 Apr 2022 3:57PM $0.095 $0.025 fallen by 73.68%
$18 Major Board Appointments and New Strategic Direction 21 Apr 2022 8:13AM $0.092 $0.025 fallen by 72.83%
$18 Final Director's Interest Notice 12 Apr 2022 4:46PM $0.100 $0.025 fallen by 75%
$18 InteliCare Appoints New CEO 12 Apr 2022 11:40AM $0.090 $0.025 fallen by 72.22%
$18 InteliCare Expands Health Metric Solutions 31 Mar 2022 8:16AM $0.077 $0.025 fallen by 67.53%
$18 InteliCare Partners with Bethanie and Optus 23 Mar 2022 8:22AM $0.084 $0.025 fallen by 70.24%
$18 Final Director's Interest Notice 28 Feb 2022 4:40PM $0.073 $0.025 fallen by 65.75%
$18 Half Yearly Report and Accounts 23 Feb 2022 6:24PM $0.075 $0.025 fallen by 66.67%
$18 Initial Director's Interest Notice 21 Feb 2022 8:21AM $0.079 $0.025 fallen by 68.35%
$18 Appointment of Dr Terry Sweeney as NED 21 Feb 2022 8:21AM $0.079 $0.025 fallen by 68.35%
$18 Quarterly Operations Update 28 Jan 2022 4:17PM $0.083 $0.025 fallen by 69.88%
$18 Appendix 4C Cash Flow Report 28 Jan 2022 4:16PM $0.083 $0.025 fallen by 69.88%
$18 Change in substantial holding 24 Dec 2021 12:01PM $0.086 $0.025 fallen by 70.93%
$18 Change in substantial holding 24 Dec 2021 8:22AM $0.085 $0.025 fallen by 70.59%

201 - 225 of 328 results

Page 9 of 14

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.